Restoration of the majority of the visual spectrum by using modified Volvox channelrhodopsin-1.
Restoration of the majority of the visual spectrum by using modified Volvox channelrhodopsin-1.
复制标题
DOI:
10.1038/mt.2014.81
复制
发表时间:
2014-08
期刊:
影响因子:
--
通讯作者:
Tamai M
中科院分区:
文献类型:
--
作者:
Tomita H;Sugano E;Murayama N;Ozaki T;Nishiyama F;Tabata K;Takahashi M;Saito T;Tamai M
We previously showed that blind rats whose vision was restored by gene transfer of Chlamydomonas channelrhodopsin-2 (ChR2) could only detect wavelengths less than 540 nm because of the action spectrum of the transgene product. Volvox-derived channelrhodopsin-1, VChR1, has a broader spectrum than ChR2. However, the VChR1 protein was mainly localized in the cytoplasm and showed weak ion channel properties when the VChR1 gene was transfected into HEK293 cells. We generated modified Volvox channelrhodopsin-1 (mVChR1), which is a chimera of Volvox channelrhodopsin-1 and Chlamydomonas channelrhodopsin-1 and demonstrated increased plasma membrane integration and dramatic improvement in its channel properties. Under whole-cell patch clamp, mVChR1-expressing cells showed a photo-induced current upon stimulation at 468–640 nm. The evoked currents in mVChR1-expressing cells were ~30 times larger than those in VChR1-expressing cells. Genetically, blind rats expressing mVChR1 via an adeno-associated virus vector regained their visual responses to light with wavelengths between 468 and 640 nm and their recovered visual responses were maintained for a year. Thus, mVChR1 is a candidate gene for gene therapy for restoring vision, and gene delivery of mVChR1 may provide blind patients access to the majority of the visible light spectrum.
登录
查看更多内容
影响因子:
2.5
作者:
Stark, Eran;Koos, Tibor;Buzsaki, Gyoergy
通讯作者:
Buzsaki, Gyoergy
影响因子:
30.8
作者:
Gal, A;Li, Y;Vollrath, D
通讯作者:
Vollrath, D
影响因子:
4.8
作者:
Sato, S;Ward, CL;Kopito, RR
通讯作者:
Kopito, RR
影响因子:
25
作者:
Boyden, ES;Zhang, F;Deisseroth, K
通讯作者:
Deisseroth, K
影响因子:
2.9
作者:
KAUSHAL, S;KHORANA, HG
通讯作者:
KHORANA, HG